Medicine for Bronchitis

As per available reports about 30 journals, 50 Conferences, 20 workshops are presently dedicated exclusively to medicine for bronchitis and about 1,300 articles are being published on the current trends in medicine for bronchitis. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to medicine for bronchitis are being carried out. As reported in 1,300 article Medicine for bronchitis is the study of proteins and ¬their structure and functions.
 

Bronchitis is an inflammation of the mucous membranes of the bronchi (the larger and medium-sized airways that carry airflow from the trachea into the more distal parts of the lung parenchyma) Bronchitis can be divided into two categories: acute and chronic.
 

The Journal of Allergy & Therapy is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in medicine for bronchitis. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Allergy & Therapy  provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of medicine for bronchitis and bioinformatics, thus bridging the gap between researchers and young scientists.